Concepedia

Samantha Mackin

SM

Statistics

Publications

14

Citations

1.2K

H-Index

14

Active since

2019

Affiliations

Washington University in St. Louis(Current)

Moderna Therapeutics (United States)

University of Iowa

Vanderbilt University Medical Center

VIR Biotechnology (United States)

Samantha Mackin is an author at Washington University in St. Louis specializing in infectious diseases, veterinary medicine, and immunology.

ORCID

Publications per year

2019–2023

14

Publications

14

3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice

Athri D. Rathnayake, Jian Zheng, Yunjeong Kim et al. · Science Translational Medicine · 2020 · 295 citations · Full text

, , +17

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

James Brett Case, Samantha Mackin, John M. Errico et al. · Nature Communications · 2022 · 154 citations · Full text

, , +16

Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2

Samantha Mackin, Pritesh Desai, Bradley Whitener et al. · Nature Microbiology · 2023 · 120 citations · Full text

, , +13

Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice

Baoling Ying, Suzanne M. Scheaffer, Bradley Whitener et al. · Cell · 2022 · 98 citations · Full text

, , +14

Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection

Alan Sariol, Samantha Mackin, Merri-Grace Allred et al. · Proceedings of the National Academy of Sciences · 2020 · 90 citations · Full text

, , +17

1–5 of 14